RadNet (RDNT)
RadNet on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-medical laboratories.
9.4M
Short interest
settlement 2026-09-30
12.8
Days to cover
+0.9 days vs prior
38.3%
Short share of volume
2026-10-09
6,449
Fails to deliver
settlement 2026-09-14
Mon 9 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in RDNT is 9,361,935 shares, down 578,954 shares over the last month. Over the last 48 readings it ranged from 3,475,065 shares (15 November 2024) to 10,425,092 shares (31 July 2026). At the reported average volume of 729K shares a day that is 12.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rdnt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 9,361,935 | -3.2% | 729,300 | 12.84 |
| 2026-09-15 | 9,671,100 | -2.7% | 810,611 | 11.93 |
| 2026-08-31 | 9,940,889 | +2.6% | 510,678 | 19.47 |
| 2026-08-14 | 9,685,408 | -7.1% | 939,210 | 10.31 |
| 2026-07-31 | 10,425,092 | +3.9% | 615,848 | 16.93 |
| 2026-07-15 | 10,036,994 | +0.3% | 881,955 | 11.38 |
| 2026-06-30 | 10,004,424 | +13.4% | 1,267,759 | 7.89 |
| 2026-06-15 | 8,819,394 | -3.8% | 768,654 | 11.47 |
| 2026-05-29 | 9,170,015 | +1.3% | 477,388 | 19.21 |
| 2026-05-15 | 9,053,285 | -0.9% | 1,126,070 | 8.04 |
| 2026-04-30 | 9,131,968 | +3.7% | 844,975 | 10.81 |
| 2026-04-15 | 8,808,033 | +1.7% | 662,491 | 13.30 |
| 2026-03-31 | 8,658,853 | +4.2% | 818,522 | 10.58 |
| 2026-03-13 | 8,310,494 | +7.7% | 1,084,842 | 7.66 |
| 2026-02-27 | 7,715,356 | -0.3% | 727,131 | 10.61 |
| 2026-02-13 | 7,739,264 | +4.8% | 775,677 | 9.98 |
| 2026-01-30 | 7,385,859 | -1.1% | 595,416 | 12.40 |
| 2026-01-15 | 7,465,239 | -5.5% | 709,968 | 10.51 |
| 2025-12-31 | 7,896,807 | -2.5% | 1,137,900 | 6.94 |
| 2025-12-15 | 8,103,361 | +10.1% | 852,282 | 9.51 |
| 2025-11-28 | 7,361,600 | +3.8% | 857,931 | 8.58 |
| 2025-11-14 | 7,089,968 | +4.5% | 993,751 | 7.13 |
| 2025-10-31 | 6,787,903 | +2.0% | 636,085 | 10.67 |
| 2025-10-15 | 6,652,229 | +4.7% | 586,194 | 11.35 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of RDNT volume is 38.3%, down 47.9 points over the last five sessions. Over the last 30 readings it ranged from 30.1% (1 September 2026) to 88.1% (18 September 2026). The latest reading is 25.2 points below the 30-session average of 63.5%, on 260K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 100K | 260K | 38.3% | 0 |
| 2026-10-08 | 171K | 318K | 53.8% | 0 |
| 2026-10-07 | 65K | 102K | 63.5% | 32 |
| 2026-10-06 | 59K | 80K | 73.8% | 0 |
| 2026-10-05 | 133K | 186K | 71.2% | 0 |
| 2026-10-02 | 199K | 231K | 86.2% | 136 |
| 2026-10-01 | 191K | 342K | 55.8% | 318 |
| 2026-09-30 | 135K | 199K | 67.9% | 20 |
| 2026-09-29 | 139K | 187K | 74.4% | 0 |
| 2026-09-28 | 115K | 166K | 69.6% | 0 |
| 2026-09-25 | 142K | 231K | 61.3% | 0 |
| 2026-09-24 | 178K | 348K | 51.0% | 1 |
| 2026-09-23 | 138K | 226K | 61.1% | 0 |
| 2026-09-22 | 176K | 283K | 62.2% | 500 |
| 2026-09-21 | 141K | 282K | 50.1% | 48 |
| 2026-09-18 | 198K | 225K | 88.1% | 0 |
| 2026-09-17 | 177K | 217K | 81.7% | 3,766 |
| 2026-09-16 | 173K | 274K | 63.2% | 0 |
| 2026-09-15 | 403K | 591K | 68.2% | 0 |
| 2026-09-14 | 254K | 611K | 41.6% | 0 |
| 2026-09-11 | 182K | 212K | 85.9% | 31,801 |
| 2026-09-10 | 249K | 295K | 84.4% | 64,961 |
| 2026-09-09 | 127K | 205K | 62.0% | 0 |
| 2026-09-08 | 86K | 137K | 62.5% | 0 |
| 2026-09-04 | 139K | 213K | 65.4% | 0 |
| 2026-09-03 | 222K | 370K | 60.1% | 0 |
| 2026-09-02 | 143K | 337K | 42.5% | 0 |
| 2026-09-01 | 110K | 365K | 30.1% | 0 |
| 2026-08-31 | 164K | 197K | 83.0% | 0 |
| 2026-08-28 | 72K | 152K | 47.1% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 September 2026, the fails-to-deliver balance in RDNT is 6,449 shares, up 3,844 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (4 June 2026) to 28,849 shares (30 July 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-14 | 6,449 | $75.49 | $487K |
| 2026-09-11 | 2,605 | $74.28 | $193K |
| 2026-09-10 | 5,936 | $70.87 | $421K |
| 2026-09-09 | 10,166 | $71.97 | $732K |
| 2026-08-27 | 1,027 | $76.47 | $79K |
| 2026-08-26 | 63 | $76.86 | $5K |
| 2026-08-24 | 212 | $76.82 | $16K |
| 2026-08-11 | 2,692 | $77.28 | $208K |
| 2026-08-06 | 164 | $67.06 | $11K |
| 2026-08-05 | 504 | $69.22 | $35K |
| 2026-08-04 | 28,696 | $66.80 | $1.9M |
| 2026-08-03 | 41 | $63.78 | $3K |
| 2026-07-30 | 28,849 | $63.37 | $1.8M |
| 2026-07-29 | 1,992 | $63.22 | $126K |
| 2026-07-27 | 2,011 | $61.57 | $124K |
| 2026-07-21 | 70 | $60.68 | $4K |
| 2026-07-20 | 2,165 | $62.19 | $135K |
| 2026-07-17 | 269 | $62.99 | $17K |
| 2026-07-16 | 2,282 | $61.41 | $140K |
| 2026-07-08 | 6 | $67.83 | $407 |
| 2026-07-06 | 2,229 | $68.75 | $153K |
| 2026-07-01 | 6 | $61.67 | $370 |
| 2026-06-30 | 8,047 | $59.28 | $477K |
| 2026-06-29 | 20,871 | $60.74 | $1.3M |
| 2026-06-24 | 19,875 | $56.20 | $1.1M |
| 2026-06-22 | 15,663 | $53.74 | $842K |
| 2026-06-18 | 2,006 | $52.82 | $106K |
| 2026-06-16 | 123 | $57.05 | $7K |
| 2026-06-11 | 38 | $58.16 | $2K |
| 2026-06-04 | 3 | $51.87 | $156 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONNo open-market insider trades were reported for RDNT in the last 90 days. The most recent filings are listed below. Latest filing: SWARTZ DAVID L (Director) on 2026-06-18.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | SWARTZ DAVID L | Director | Sell | 3K | $53.89 | $145K | 177K |
| 2026-06-16 | Wesdorp Cornelis | Pres & CEO, Digital Health | Sell | 5K | $58.11 | $276K | 69K |
| 2026-06-16 | Berger Howard G | President, CEO | Gift | 90 | $0.00 | $0 | 20K |
| 2026-06-15 | Forthuber Stephen M | Pres & CEO-Eastern Operations | Sell | 24K | $57.79 | $1.4M | 527K |
| 2026-06-15 | Forthuber Stephen M | Pres & CEO-Eastern Operations | Sell | 20K | $58.61 | $1.2M | 507K |
| 2026-06-02 | SWARTZ DAVID L | Director | Grant | 3K | $0.00 | $0 | 180K |
| 2026-06-02 | SPURLOCK GREGORY E. | Director | Grant | 3K | $0.00 | $0 | 8K |
| 2026-06-02 | Levitt Lawrence L | Director | Grant | 3K | $0.00 | $0 | 168K |
| 2026-06-02 | Jacobs Laura Pastre | Director | Grant | 3K | $0.00 | $0 | 30K |
| 2026-05-05 | Berger Howard G | President, CEO | Option exercise | 26K | $18.64 | $484K | 498K |
| 2026-03-19 | Sorensen Alma Gregory | Chief Strategy Officer | Gift | 7K | $0.00 | $0 | 1.2M |
| 2026-03-19 | Sorensen Alma Gregory | Chief Strategy Officer | Sell | 100 | $63.59 | $6K | 1.2M |
| 2026-03-19 | Sorensen Alma Gregory | Chief Strategy Officer | Sell | 5K | $62.82 | $336K | 1.2M |
| 2026-03-19 | Sorensen Alma Gregory | Chief Strategy Officer | Sell | 10K | $61.84 | $591K | 1.2M |
| 2026-03-18 | Sorensen Alma Gregory | Chief Strategy Officer | Sell | 800 | $62.72 | $50K | 1.2M |
| 2026-03-18 | Sorensen Alma Gregory | Chief Strategy Officer | Sell | 14K | $62.12 | $882K | 1.2M |
| 2026-03-16 | Sorensen Alma Gregory | Chief Strategy Officer | Tax withholding | 6K | $61.72 | $365K | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 17K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 2K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 12K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 9K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 7K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 6K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 5K | $0.00 | $0 | 1.2M |
| 2026-03-10 | Sorensen Alma Gregory | Chief Strategy Officer | Option exercise | 4K | $0.00 | $0 | 1.2M |
| 2026-03-03 | Wesdorp Cornelis | Pres & CEO, Digital Health | Grant | 20K | $0.00 | $0 | 74K |
| 2026-03-03 | STOLPER MARK | EVP, Chief Financial Officer | Grant | 18K | $0.00 | $0 | 122K |
| 2026-03-03 | Sorensen Alma Gregory | EVP, Chief Science Officer | Grant | 17K | $0.00 | $0 | 1.2M |
| 2026-03-03 | Patel Mital | EVP of Fin Planning, CAO | Grant | 21K | $0.00 | $0 | 200K |
| 2026-03-03 | Murdock Michael N | EVP, Mergers and Acquisitions | Grant | 7K | $0.00 | $0 | 47K |
| 2026-03-03 | Katz David Jeffrey | EVP and Chief Legal Officer | Grant | 19K | $0.00 | $0 | 91K |
| 2026-03-03 | HAMES NORMAN R | Pres and COO-West Operations | Grant | 3K | $0.00 | $0 | 23K |
| 2026-03-03 | HAMES NORMAN R | Pres and COO-West Operations | Grant | 22K | $0.00 | $0 | 261K |
| 2026-03-03 | Forthuber Stephen M | Pres & COO-Eastern Operations | Grant | 22K | $0.00 | $0 | 551K |
| 2026-03-03 | Berger Howard G | President, CEO | Grant | 124K | $0.00 | $0 | 472K |
| 2025-12-10 | STOLPER MARK | EVP, Chief Financial Officer | Option exercise | 36K | $6.07 | $217K | 104K |
| 2025-12-10 | Katz David Jeffrey | EVP and Chief Legal Officer | Option exercise | 3K | $29.44 | $100K | 72K |
| 2025-12-05 | Forthuber Stephen M | Pres & COO-Eastern Operations | Sell | 2K | $79.77 | $136K | 529K |
| 2025-12-05 | Forthuber Stephen M | Pres & COO-Eastern Operations | Sell | 12K | $79.06 | $917K | 531K |
| 2025-12-05 | Forthuber Stephen M | Pres & COO-Eastern Operations | Sell | 32K | $77.99 | $2.5M | 543K |
| 2025-12-03 | Forthuber Stephen M | Pres & COO-Eastern Operations | Option exercise | 39K | $6.07 | $238K | 574K |
| 2025-12-03 | Patel Mital | EVP of Fin Planning, CAO | Gift | 630 | $0.00 | $0 | 180K |
| 2025-11-25 | Levitt Lawrence L | Director | Gift | 3K | $0.00 | $0 | 165K |
| 2025-11-19 | Patel Mital | EVP of Fin Planning, CAO | Sell | 15K | $80.05 | $1.2M | 180K |
| 2025-11-19 | Berger Howard G | President, CEO | Option exercise | 26K | $18.64 | $484K | 348K |
| 2025-11-19 | Berger Howard G | President, CEO | Option exercise | 104K | $18.64 | $1.9M | 322K |
| 2025-11-18 | Patel Mital | EVP of Fin Planning, CAO | Sell | 10K | $80.00 | $794K | 195K |
| 2025-11-17 | Patel Mital | EVP of Fin Planning, CAO | Sell | 25K | $76.06 | $1.9M | 205K |
| 2025-11-13 | Murdock Michael N | EVP, Mergers and Acquisitions | Gift | 3K | $0.00 | $0 | 40K |
| 2025-09-16 | Katz David Jeffrey | EVP and Chief Legal Officer | Sell | 14K | $74.44 | $1.0M | 68K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON12 Form 144 notices on file for RDNT worth $17.8M at the prices reported; 0 in the last 90 days worth $0. Latest: DAVID SWARTZ filed on 2026-06-18 to sell 2,699 shares ($145K) from 2026-06-18.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-18 | DAVID SWARTZDirector | 3K | $145K | 0.003% | 2026-06-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-16 | Cornelis WesdorpOfficer | 5K | $269K | 0.006% | 2026-06-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | STEPHEN M FORTHUBEROfficer | 44K | $2.6M | 0.056% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-19 | ALMA GREGORY SORENSEN &KRISTIINA HARRISON SORENSENDirector, Board of Director | 15K | $933K | 0.019% | 2026-03-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-18 | ALMA GREGORY SORENSEN &KRISTIINA HARRISON SORENSENDirector, Board of Director | 15K | $932K | 0.019% | 2026-03-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-18 | ALMA GREGORY SORENSENDirector, Board of Director | 6K | $379K | 0.008% | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-05 | STEPHEN M FORTHUBEROfficer | 45K | $3.5M | 0.058% | 2025-12-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-19 | Patel MitalOfficer | 25K | $2.7M | 0.032% | 2025-11-19 | Raymond James & Associates |
| 2025-11-19 | Patel MitalOfficer | 10K | $794K | 0.013% | 2025-11-18 | Raymond James & Associates |
| 2025-11-19 | Patel MitalOfficer | 25K | $1.9M | 0.032% | 2025-11-17 | Raymond James & Associates |
| 2025-09-16 | David Jeffrey KatzOfficer | 14K | $1.0M | 0.018% | 2025-09-16 | The Charles Schwab Corporation |
| 2025-09-15 | STOLPER MARKOfficer | 35K | $2.6M | 0.046% | 2025-09-15 | Merrill Lynch |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of RDNT in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 12.0% of the class (9,250,663 shares), filed 2025-10-17 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | RTW Investments, LPinvestment adviser, partnership | 4.8M | 6.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Roderick Wongparent holding company, individual | 4.8M | 6.2% | 2026-06-30 |
| 2026-05-15 | 13G | T. Rowe Price Associates, Inc.investment adviser | 4.2M | 5.4% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 4.0M | 5.1% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 8 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-10-17 | 13G/Ano. 8 | BlackRock, Inc.parent holding company, parent holding company | 9.3M | 12.0% | 2025-09-30 |
13F holders
Tracked managers holding RDNT at their latest 13F. JSON4 of the 30 tracked managers held RDNT at their latest 13F, $69.3M in total at quarter-end prices. Point72 Asset Management is the largest at $30.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 492K | $30.4M | 0.03% | -363K |
| Millennium Management | 2026-06-30 | 466K | $28.7M | 0.01% | +419K |
| Soros Fund Management | 2026-06-30 | 117K | $7.2M | 0.09% | -322K |
| AQR Capital Management | 2026-06-30 | 50K | $3.1M | 0.00% | +34K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) RadNet reported revenue of $622.7M, up 25.0% from the same quarter a year earlier, and net income of $7.5M (0.10 diluted EPS). In FY 2025 it generated $298.8M of operating cash flow. As of 2026-06-30, cash was $726.3M against $1.33B of debt.
- Cash
- $726.3M
- Debt
- $1.33B
- Equity
- $1.10B
- Total assets
- $4.23B
- Shares outstanding
- 78,697,257
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $622.7M | $7.5M | 1.2% | 0.10 |
| Q1 FY 2026 | 2026-03-31 | $575.6M | -$33.5M | -5.8% | -0.43 |
| Q4 FY 2025derived | 2025-12-31 | $547.7M | -$597K | -0.1% | n/a |
| Q3 FY 2025 | 2025-09-30 | $522.9M | $5.4M | 1.0% | 0.07 |
| Q2 FY 2025 | 2025-06-30 | $498.2M | $14.5M | 2.9% | 0.19 |
| Q1 FY 2025 | 2025-03-31 | $471.4M | -$37.9M | -8.0% | -0.51 |
| Q4 FY 2024derived | 2024-12-31 | $477.1M | $5.3M | 1.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $461.1M | $3.2M | 0.7% | 0.04 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.04B | -$18.7M | $298.8M | $213.3M | n/a | n/a |
| FY 2024 | 2024-12-31 | $1.83B | $2.8M | $233.0M | $188.1M | n/a | n/a |
| FY 2023 | 2023-12-31 | $1.62B | $3.0M | $220.9M | $176.6M | n/a | n/a |
| FY 2022 | 2022-12-31 | $1.43B | $10.7M | $146.4M | $119.5M | n/a | n/a |
| FY 2021 | 2021-12-31 | $1.32B | $24.7M | $149.5M | $137.9M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-06 from the cover page.
What this page is
RadNet in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows RadNet (RDNT), SEC CIK 790526, listed on Nasdaq, classified by the SEC as services-medical laboratories. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-18.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-18.JSON and CSV
- Company record
- EDGAR filing index for CIK 790526Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-medical laboratories
Other company pages
Datasets
Frequently Asked Questions
How much of RDNT is sold short?
What is RDNT's daily short volume?
Does RDNT have fails to deliver?
Are RDNT insiders buying or selling?
Have RDNT insiders filed to sell?
Who owns 5% or more of RDNT?
What did RDNT report last quarter?
Which tracked 13F managers own RDNT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.